Previous studies establishing the i-motif within the BCL2 promoter as a transcriptional activator [46,47] support the premise that stabilization of the BCL2 i-motif in NAFLD and NASH is an effective approach to increase BCL2 levels and prevent hepatocyte apoptosis. The gene discussed is BCL2; the disease is metabolic dysfunction-associated steatohepatitis.